Oncology
12 Questions with Julia Jakl
Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles
Polarized debate about drugs harms patients

Polarized debate about drugs harms patients

John LaMattina highlights the harm that polarized debates around drugs can cause to patients. The ongoing debate between critics of the pharmaceutical industry and the industry itself is starting to mimic the current, party-based...

Articles
Pharma pricing & market access outlook Europe 2013

Pharma pricing & market access outlook Europe 2013

Rebecca Aris provides an overview of day one of the ‘Pharma pricing & market access outlook Europe 2013’ event. ‘May you live in interesting times’, a phrase widely used in Asia, was used to open the day’s session by Ed Schoonveld...

Articles
The importance of traditional news media coverage in a 3.0 world

The importance of traditional news media coverage in a 3.0 w...

Laura Liotta shares her opinion that traditional media still plays a significant role in the communication mix, despite the increase in social media channels – do you agree? It has been more than a decade since media platforms such as blogs, forums, online communities and social networks emerged with...

Sales & Marketing

Sales & Marketing
Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
12 Questions with Julia Jakl
Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Patients

R&D